IPO · NEPHROPLUS

Nephrocare Health Services IPO listing gain & performance.

Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.

· data for the trading session of Wed 18 Nov 2026

Issue price₹460.00₹438 to ₹460
Listing gain+6.5%at the opening price
Since the IPO+42.0%₹653.00 on 18 Nov
Subscribed14.0×times in total

Nephrocare Health Services IPO in brief

Written from NSE’s data, as of 18 Nov 2026.

Nephrocare Health Services came to the market at ₹460.00 a share (price band ₹438 to ₹460), with bidding open from 10 December to 12 December 2025. It listed on NSE on Wednesday, 17 December 2025, opening at ₹490.00, a gain of 6.5% on the issue price, and closed the first day +2.4% from the issue price after trading between +0.8% and +8.5%. 55% of the first day’s traded shares were taken for delivery.

The issue was subscribed 14.0× in total, institutions (QIB) 27.5×, HNIs (NII) 24.3×, retail investors 2.31×. Across the 46 IPOs subscribed 10–50×, the median listing gain was +7.5%.

Its listing gain beat 46% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 6 months after listing it was +47.8% from the issue price and +44.2% from the first-day close, while NIFTY 50 moved -7.0% over the same days. Its highest price so far was 70% above the issue price (11 Sep 2026) and its lowest 3% below it (19 Dec 2025); it closed below the issue price on 1% of the days since listing.

Share price since listing

Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.

IPO ₹46017 Dec 202518 Nov 2026₹653

Subscription

Times subscribed by investor group, NSE + BSE bids as reported by NSE.

Qualified institutions (QIB)27.5×
Non-institutional (NII / HNI)24.3×
NII, bids above ₹10 lakh29.8×
NII, ₹2–10 lakh13.2×
Retail investors2.31×
Employees2.67×
Total14.0×

For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.

Listing day

Wednesday 17 December 2025.

Open+6.5%vs issue price
High / low+8% / +1%vs issue price
Close+2.4%vs issue price
Delivery55%₹742 Cr traded

Returns after listing

Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.

After listingFrom issue priceFrom first-day closeNIFTY 50Median IPO (from issue)
1 week24 Dec 2025+3.3%+0.9%+1.3%+8.0%
1 month19 Jan 2026+11.8%+9.2%-0.9%+9.4%
3 months19 Mar 2026+15.1%+12.4%-10.9%+10.3%
6 months24 Jun 2026+47.8%+44.2%-7.0%+8.0%

IPO details

From NSE’s issue page.

Company
Nephrocare Health Services
NSE symbol
NEPHROPLUS
Board
Main board
Industry
Healthcare Service Provider
Bidding
10 Dec – 12 Dec 2025
Price band
₹438 to ₹460
Issue price
₹460.00
Issue size
Initial Public Offer for fresh issue of equity shares aggregating upto Rs. 3534.05 million and Offer for Sale upto 11,253,102 equity shares (including Eligible Employee Reservation Portion aggregating upto Rs. 35 million and Anchor investors portion of 56,57,919 Equity Shares)
Bid lot
32 Equity Shares and in multiples thereof
Listing date
17 December 2025
ISIN
INE428V01029

Nephrocare Health Servic share price, delivery & results →How all IPOs did after listing →IPO calendar →

Questions

What was the listing gain of the Nephrocare Health Services IPO?
Nephrocare Health Services listed on 17 December 2025 and opened +6.5% against its issue price of ₹460.00; it closed the first day +2.4% from the issue price.
What is the Nephrocare Health Services share price now against the IPO price?
At the close of 18 November 2026, Nephrocare Health Services was at ₹653.00, +42.0% from the IPO price of ₹460.00.
How many times was the Nephrocare Health Services IPO subscribed?
Nephrocare Health Services’s IPO was subscribed 14.0× in total; QIB 27.5×; NII 24.3×; retail 2.31× (NSE + BSE bids, as reported by NSE).
When was the Nephrocare Health Services IPO open?
Bidding ran from 10 December to 12 December 2025 at a price band of ₹438 to ₹460; the shares listed on 17 December 2025.

From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.

See it live on your chart.ChartMine for TradingView.